Authors:
Frank Hullekes1, Rucháma Verhoeff1, Paolo Cravedi1, and Leonardo V. Riella1
Abstract:
Focal segmental glomerulosclerosis (FSGS) recurrence post-transplantation represents one of the most challenging conditions causing kidney allograft failure. Despite intensive research over the past decades, many gaps remain in understanding its pathophysiology. Herein, we review several questions highlighting recent advancements and their potential use in clinical practice.
